Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Baxter International (NY: BAX )

35.51 +0.42 (+1.20%)
Official Closing Price Updated: 7:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,470,476
Open 35.35
Bid (Size) 35.15 (3)
Ask (Size) 35.88 (3)
Prev. Close 35.09
Today's Range 35.10 - 35.86
52wk Range 31.01 - 49.07
Shares Outstanding 499,910,255
Dividend Yield 3.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private... 
Via Benzinga
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire

Performance

YTD
-8.60%
-8.60%
1 Month
+4.56%
+4.56%
3 Month
-11.73%
-11.73%
6 Month
-8.93%
-8.93%
1 Year
-27.46%
-27.46%

More News

Read More
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
How Is The Market Feeling About Baxter Intl?
Via Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
From Baxter International Inc.
Via Business Wire
3 Bargain Bin Stocks with Millionaire-Maker Potential
Via InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
Via Benzinga
(BAX) - Analyzing Baxter Intl's Short Interest
Via Benzinga
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
Via Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
Via Talk Markets
Topics Economy
Exposures Interest Rates
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
7 Deeply Undervalued Stocks to Buy Now or Regret Later
Via InvestorPlace
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
From Baxter International Inc.
Via Business Wire
3 Dividend Growth Stocks For Long-Term Returns
Via Talk Markets
Baxter to Present at Jefferies 2024 Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Via Benzinga
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
From Baxter International Inc.
Via Business Wire
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
From Baxter International Inc.
Via Business Wire
Baxter to Present at Bank of America 2024 Health Care Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.